Marion McCourt has been appointed senior vice president and head of commercial, Regeneron Pharmaceuticals. Ms. McCourt will lead all aspects of product commercialization for the company’s currently approved medicines and development-stage pipeline. Ms. McCourt has more than two decades of experience in biopharmaceutical management with an emphasis on commercial strategy and execution. Most recently, she served as chief operating officer of Medivation until its acquisition by Pfizer in 2016, a...